Alexander Fosså

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma

Peter Johnson, Massimo Federico, Amy A. Kirkwood et al. · New England Journal of Medicine · 2016 · 798 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg et al. · Blood · 2017 · 624 citations · Full text

Life Sciences, Hematology, Virology +4

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial

Frits van Rhee, Raymond Wong, Nikhil C. Munshi et al. · The Lancet Oncology · 2014 · 442 citations

Life Sciences, Immunology, Internal Medicine +5

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Frits van Rhee, Peter M. Voorhees, Angela Dispenzieri et al. · Blood · 2018 · 414 citations · Full text

Medicine, Internal Medicine, Integrated Disease Management +4

Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study

Christine Mauz‐Körholz, Dirk Hasenclever, W Dörffel et al. · Journal of Clinical Oncology · 2010 · 260 citations

Medicine, Oncology, Pediatrics +15